Cargando…
Advances and Challenges of Cannabidiol as an Anti-Seizure Strategy: Preclinical Evidence
The use of Cannabis for medicinal purposes has been documented since ancient times, where one of its principal cannabinoids extracted from Cannabis sativa, cannabidiol (CBD), has emerged over the last few years as a promising molecule with anti-seizure potential. Here, we present an overview of rece...
Autores principales: | Zavala-Tecuapetla, Cecilia, Luna-Munguia, Hiram, López-Meraz, María-Leonor, Cuellar-Herrera, Manola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783044/ https://www.ncbi.nlm.nih.gov/pubmed/36555823 http://dx.doi.org/10.3390/ijms232416181 |
Ejemplares similares
-
Insights into Potential Targets for Therapeutic Intervention in Epilepsy
por: Zavala-Tecuapetla, Cecilia, et al.
Publicado: (2020) -
Preclinical and Clinical Evidence Supporting Use of Cannabidiol in Psychiatry
por: Calapai, Gioacchino, et al.
Publicado: (2019) -
Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions
por: Anderson, Lyndsey L., et al.
Publicado: (2019) -
Evidences for the Anti-panic Actions of Cannabidiol
por: Soares, Vanessa P., et al.
Publicado: (2017) -
Cannabidiol Acts at 5-HT(1A) Receptors in the Human Brain: Relevance for Treating Temporal Lobe Epilepsy
por: Martínez-Aguirre, Christopher, et al.
Publicado: (2020)